A data-independent acquisition workflow for qualitative screening of new psychoactive substances in biological samples

Identification of new psychoactive substances (NPS) is challenging. Developing targeted methods for their analysis can be difficult and costly due to their impermanence on the drug scene. Accurate-mass mass spectrometry (AMMS) using a quadrupole time-of-flight (QTOF) analyzer can be useful for wide-scope screening since it provides sensitive, full-spectrum MS data. Our article presents a qualitative screening workflow based on data-independent acquisition mode (all-ions MS/MS) on liquid chromatography (LC) coupled to QTOFMS for the detection and identification of NPS in biological matrices. The workflow combines and structures fundamentals of target and suspect screening data processing techniques in a structured algorithm. This allows the detection and tentative identification of NPS and their metabolites. We have applied the workflow to two actual case studies involving drug intoxications where we detected and confirmed the parent compounds ketamine, 25B-NBOMe, 25C-NBOMe, and several predicted phase I and II metabolites not previously reported in urine and serum samples. The screening workflow demonstrates the added value for the detection and identification of NPS in biological matrices.

[1]  C. Morgan,et al.  Ketamine use: a review. , 2012, Addiction.

[2]  W. Maho,et al.  Sewage-based epidemiology in monitoring the use of new psychoactive substances: Validation and application of an analytical method using LC-MS/MS. , 2015, Drug testing and analysis.

[3]  T. Baillie,et al.  Studies on the biotransformation of ketamine. 1-Identification of metabolites produced in vitro from rat liver microsomal preparations. , 1981, Biomedical mass spectrometry.

[4]  B. Logan.  Amphetamines: an update on forensic issues. , 2001, Journal of analytical toxicology.

[5]  M. Nielen,et al.  Preventive doping control analysis: liquid and gas chromatography time-of-flight mass spectrometry for detection of designer steroids. , 2007, Rapid communications in mass spectrometry : RCM.

[6]  Lubertus Bijlsma,et al.  Rapid wide-scope screening of drugs of abuse, prescription drugs with potential for abuse and their metabolites in influent and effluent urban wastewater by ultrahigh pressure liquid chromatography-quadrupole-time-of-flight-mass spectrometry. , 2011, Analytica chimica acta.

[7]  C. Erratico,et al.  In vitro and in vivo human metabolism of the synthetic cannabinoid AB-CHMINACA. , 2015, Drug testing and analysis.

[8]  Mark Wrona,et al.  'All-in-one' analysis for metabolite identification using liquid chromatography/hybrid quadrupole time-of-flight mass spectrometry with collision energy switching. , 2005, Rapid communications in mass spectrometry : RCM.

[9]  H. Neels,et al.  Optimization, validation, and the application of liquid chromatography-tandem mass spectrometry for the analysis of new drugs of abuse in wastewater. , 2014, Drug testing and analysis.

[10]  R. K. Siegel.  Phencyclidine and ketamine intoxication: a study of four populations of recreational users. , 1978, NIDA research monograph.

[11]  Malcolm J Reid,et al.  Analysis of new classes of recreational drugs in sewage: synthetic cannabinoids and amphetamine-like substances. , 2014, Drug testing and analysis.

[12]  Siegel Rk.  Phencyclidine and ketamine intoxication: a study of four populations of recreational users. , 1978 .

[13]  Emma L. Schymanski,et al.  Identifying small molecules via high resolution mass spectrometry: communicating confidence. , 2014, Environmental science & technology.

[14]  R. Braithwaite,et al.  Use of Human Microsomes and Deuterated Substrates: An Alternative Approach for the Identification of Novel Metabolites of Ketamine by Mass Spectrometry , 2009, Drug Metabolism and Disposition.

[15]  M. Evans-Brown,et al.  New Psychoactive Substances in Europe. An Update from the EU Early Warning System , 2015 .

[16]  Morna L Gonsoulin,et al.  Pathological Findings in 2 Cases of Fatal 25I-NBOMe Toxicity , 2014, The American journal of forensic medicine and pathology.

[17]  I. Papoutsis,et al.  25B-NBOMe and its precursor 2C-B: modern trends and hidden dangers , 2014, Forensic Toxicology.

[18]  Thomas Kraemer,et al.  Liquid chromatography, in combination with a quadrupole time-of-flight instrument (LC QTOF), with sequential window acquisition of all theoretical fragment-ion spectra (SWATH) acquisition: systematic studies on its use for screenings in clinical and forensic toxicology and comparison with informatio , 2014, Analytical chemistry.

[19]  B. Thomas,et al.  Analysis of synthetic cannabinoids using high-resolution mass spectrometry and mass defect filtering: implications for nontargeted screening of designer drugs. , 2012, Analytical chemistry.

[20]  Dariusz Zuba,et al.  Identification of cathinones and other active components of ‘legal highs’ by mass spectrometric methods , 2012 .

[21]  E. Vuori,et al.  Toxicological screening of urine for drugs by liquid chromatography/time-of-flight mass spectrometry with automated target library search based on elemental formulas. , 2001, Rapid communications in mass spectrometry : RCM.

[22]  Lubertus Bijlsma,et al.  Fragmentation pathways of drugs of abuse and their metabolites based on QTOF MS/MS and MS(E) accurate-mass spectra. , 2011, Journal of mass spectrometry : JMS.

[23]  Nikolaos S. Thomaidis,et al.  Targeted and non-targeted liquid chromatography-mass spectrometric workflows for identification of transformation products of emerging pollutants in the aquatic environment , 2015 .

[24]  Adrian Covaci,et al.  Comprehensive analytical strategies based on high-resolution time-of-flight mass spectrometry to identify new psychoactive substances , 2014 .

[25]  Martin Krauss,et al.  LC–high resolution MS in environmental analysis: from target screening to the identification of unknowns , 2010, Analytical and bioanalytical chemistry.

[26]  D. Zuba,et al.  25C-NBOMe--new potent hallucinogenic substance identified on the drug market. , 2013, Forensic science international.

[27]  E. Fornal.  Study of collision-induced dissociation of electrospray-generated protonated cathinones. , 2014, Drug testing and analysis.

[28]  Emma L. Schymanski,et al.  Strategies to characterize polar organic contamination in wastewater: exploring the capability of high resolution mass spectrometry. , 2014, Environmental science & technology.

[29]  C. McKay,et al.  Ketamine abusers presenting to the emergency department: a case series. , 2000, The Journal of emergency medicine.

[30]  S Hudson,et al.  Analysis of anonymous pooled urine from portable urinals in central London confirms the significant use of novel psychoactive substances. , 2013, QJM : monthly journal of the Association of Physicians.

[31]  Gennifer E. Merrihew,et al.  Deconvolution of mixture spectra from ion-trap data-independent-acquisition tandem mass spectrometry. , 2010, Analytical chemistry.

[32]  Michelle Wood,et al.  Taking the Pissoir – a novel and reliable way of knowing what drugs are being used in nightclubs , 2014 .

[33]  T. Mak,et al.  Two cases of severe intoxication associated with analytically confirmed use of the novel psychoactive substances 25B-NBOMe and 25C-NBOMe , 2014, Clinical toxicology.

[34]  L. Ström,et al.  Liquid chromatography/time-of-flight mass spectrometry analysis of postmortem blood samples for targeted toxicological screening , 2013, Analytical and Bioanalytical Chemistry.

[35]  E. Vuori,et al.  Toxicological screening with formula-based metabolite identification by liquid chromatography/time-of-flight mass spectrometry. , 2003, Analytical chemistry.

[36]  M. Heinonen,et al.  Use of illicit stimulant drugs in Finland: a wastewater study in ten major cities. , 2014, The Science of the total environment.

[37]  Félix Hernández,et al.  Target and non-target screening strategies for organic contaminants, residues and illicit substances in food, environmental and human biological samples by UHPLC-QTOF-MS , 2012 .

[38]  Steffen Neumann,et al.  Solving CASMI 2013 with MetFrag, MetFusion and MOLGEN-MS/MS. , 2014, Mass spectrometry.

[39]  M. Gorenstein,et al.  The detection, correlation, and comparison of peptide precursor and product ions from data independent LC‐MS with data dependant LC‐MS/MS , 2009, Proteomics.

[40]  C. Wolf,et al.  Determination of 4-bromo-2,5-dimethoxy-N-[(2-methoxyphenyl)methyl]-benzeneethanamine (25B-NBOMe) in serum and urine by high performance liquid chromatography with tandem mass spectrometry in a case of severe intoxication. , 2014, Drug testing and analysis.

[41]  Malcolm J Reid,et al.  Using biomarkers in wastewater to monitor community drug use: a conceptual approach for dealing with new psychoactive substances. , 2014, The Science of the total environment.

[42]  Tania Portolés,et al.  Advancing towards universal screening for organic pollutants in waters. , 2015, Journal of hazardous materials.